Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Maravai Lifesciences Holdings, Inc. (MRVI)  
$2.41 0.06 (2.43%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 149,550,000
Market Cap: 360.42(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.72 - $9.73
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Maravai is a holding company. Through its subsidiaries, Co. operates as a life sciences company that provides products to enable the development of drug, therapies, diagnostics, vaccines, and support research on human diseases. Co. operates in two segments: Nucleic Acid Production, which includes messenger ribonucleic acid, long and short oligonucleotides, its CleanCap® capping technology and oligonucleotide building blocks; and Biologics Safety Testing, which sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 192,500 192,500
Total Buy Value $0 $0 $1,087,625 $1,087,625
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 0 25,000 25,000 9,965,974
Total Sell Value $0 $125,750 $125,750 $97,696,410
Total People Sold 0 1 1 2
Total Sell Transactions 0 1 1 2
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 167
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Asarpota Rajesh Chief Financial Officer   •       –      –    2025-06-30 4 A $0.00 $0 D/D 500,000 500,000     -
   Mihas Constantine S Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 138,055     -
   Lucier Gregory T Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 144,262     -
   Cunningham Sean Laurence Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 138,055     -
   Daverman Benjamin James Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 138,055     -
   Marker Luke Joseph Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 138,055     -
   Hopfield Jessica Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 199,907     -
   Eckert R Andrew Director   –       •      –    2025-06-16 4 A $2.16 $499,999 D/D 231,481 365,890     -
   Gray Susannah Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 169,907     -
   Prahalad Murali Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 154,607     -
   Deford John A Director   –       •      –    2025-06-16 4 A $2.16 $192,540 D/D 89,139 159,185     -
   Brust Bernd Chief Executive Officer   •       •      –    2025-06-08 4 A $0.00 $0 D/D 2,000,000 2,000,000     -
   Dolan Christine See Remarks   •       –      –    2025-05-15 4 A $1.67 $3,976 D/D 2,381 473,607     -
   Herde Kevin Chief Financial Officer   •       –      –    2025-05-15 4 A $1.67 $1,463 D/D 876 674,636     -
   Leddy Peter Michael See Remarks   •       –      –    2025-03-17 4 A $0.00 $0 D/D 394,478 732,331     -
   Oreshack Kurt General Counsel   •       –      –    2025-03-17 4 D $2.64 $12,089 D/D (4,579) 161,011     -
   Buzzeo Rebecca See Remarks   •       –      –    2025-03-17 4 D $2.64 $11,389 D/D (4,314) 310,933     -
   Leddy Peter Michael See Remarks   •       –      –    2025-03-17 4 D $2.64 $15,539 D/D (5,886) 337,853     -
   Buzzeo Rebecca See Remarks   •       –      –    2025-03-17 4 A $0.00 $0 D/D 295,858 606,791     -
   Martin William E. Iii Chief Executive Officer   •       –      –    2025-03-17 4 A $0.00 $0 D/D 986,194 1,814,643     -
   Dolan Christine See Remarks   •       –      –    2025-03-17 4 D $2.64 $14,087 D/D (5,336) 224,677     -
   Herde Kevin Chief Financial Officer   •       –      –    2025-03-17 4 A $0.00 $0 D/D 394,478 673,760     -
   Oreshack Kurt General Counsel   •       –      –    2025-03-17 4 A $0.00 $0 D/D 295,858 456,869     -
   Herde Kevin Chief Financial Officer   •       –      –    2025-03-17 4 D $2.64 $22,831 D/D (8,648) 279,282     -
   Dolan Christine See Remarks   •       –      –    2025-03-17 4 A $0.00 $0 D/D 246,549 471,226     -
  167 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us